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For 40 years the American College of Cardiology has been 
a responsible organization in promoting the art and science 
of cardiac care for people of all ages. This review chronicles 
the leapfrogging of medical and surgical creativity and 
contributions to saving lives and making those lives healthy 
through informed care for people with congenital heart 
disease. 
(.I Am Co11 Cardiol1989;13:1453-7) 
This tale of steady progress honors the American College of 
Cardiology for contributions during the past 40 years in the 
art and science of care for patients with congenital heart 
disease. Our story begins 10 years earlier. 
We have done little to prevent congenital 
heart disease but we have done lots to save lives 
in the 50 years since Robert Gross successfully 
tied off a patent ductus arteriosus (1). He did 
that at the time when diagnostic skills depended 
on a stethoscope, a three lead electrocardiogram 
(ECG) and a chest radiograph. Anesthesia was 
by gas, oxygen and open-drop ether. Recovery 
took place because of loving care and not with 
the benefit of antibiotics or even sulfonamides 
development of cardiac catheterization and uniplane, cut 
film angiocardiography. 
The independent reports by Crafoord and Nylin (3) and 
Gross and Hufnagel(4) of relief of coarctation of the aorta by 
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and without any of the accoutrements we associate with 
intensive care suites. 
The beginnings. The state of the art began to flower after 
1944 when Helen Taussig and Alfred Blalock teamed up for 
the first blue baby operation, the subclavian to pulmonary 
artery anastomosis (2). Sulfa drugs and penicillin were 
available and the use of unipolar ECGs with limb and 
precordial leads was just beginning. The excitement that 
accompanied the miracle of turning a handicapped blue baby 
or child into an active person with pink color stimulated the 
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resection and end to end anastomosis were soon 
followed by the method of Brock (5) and Sellers 
(6) for providing transvalvular relief of valvular 
pulmonary stenosis by insertion of a valvulo- 
tome through an incision in the right ventricle. 
Closed heart surgery thus became established. 
Medical management advanced, too: im- 
proved treatment of heart failure by use of 
cardiac glycosides, rather than digitalis leaf, in 
dosages based on the weight of the infant or 
child (7); diuretics were chiefly mercurials. This same period 
saw successful treatment of bacterial endocarditis with a 
month of penicillin administration and the promotion of the 
concept of prevention of that complication through prophy- 
lactic use of antibiotics at times of high risk such as after 
dental extractions. The beneficial effect of IO days of oral 
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penicillin for patients with identified B-hemolytic strepto- 
coccal pharyngitis came to be recognized and translated into 
programs for primary and secondary prevention of rheu- 
matic fever and rheumatic heart disease. Now valvular heart 
disease is uncommon. 
In this country the American College of Cardiology and 
the American Heart Association were leaders not only in the 
research and promotion of these programs of treatment and 
prevention of rheumatic fever, but also in encouraging the 
development of teams of cardiologists and surgeons dedi- 
cated to the common goal of saving the lives of people with 
congenital heart disease. This became the chief challenge in 
heart disease of the young as rheumatic fever began to 
decline. 
Developments that made possible today’s state of the art 
care. The 1950s brought diagnosis and treatment to new 
heights, with Helen Taussig and Alfred Blalock leading the 
way in the team approach in long-term follow-up and training 
programs. Diagnostic methodology advanced with biplane 
cut film angiocardiography, cineangiocardiography (8) and 
the combination of cardiac catheterization with selective 
injection of contrast medium, together with techniques for 
combined left and right heart studies. Miniaturization of 
sampling techniques and development of soft catheters made 
it possible to begin to study even the small, sick baby in need 
of accurate diagnosis and surgical relief. 
Not all handicapping anomalies were extracardiac; ex- 
ploration of how to see and repair conditions such as 
pulmonary stenosis and atria1 septal defect led to the use of 
hypothermia and inflow occlusion for treatment of these two 
malformations that could be relieved quickly in the limited 
time available by this form of circulatory arrest. In Canada, 
Bigelow and his coworkers (9) led in the next step forward of 
general hypothermia in surgery for congenital heart disease. 
Another approach to salvage of babies was for the 
common intracardiac anomaly of a large ventricular septal 
defect, with failure to thrive and with cardiac failure that 
could not be controlled despite intensive medical manage- 
ment (10). Surgical palliation (pulmonary artery banding) 
was offered by Muller (surgeon) and Dammann (pediatrician) 
(11). They created a new lesion, pulmonary stenosis, by 
banding the pulmonary artery to stem the excessive flow of 
blood through the defect and into the pulmonary artery. 
C. Walton Lillehei (12) pioneered open heart surgery as 
we know it today with his dramatic use in the mid 195Os, of 
controlled cross circulation and then the bubble oxygenator 
to close septal defects and repair tetralogy of Fallot. Kirklin 
and coworkers (13) adopted the membrane oxygenator of 
Gibbons et al. (14) to perfect and expand the art and science 
of surgery for congenital heart disease. These two Minnesota 
surgeons and their pediatric and medical colleagues were 
joined by cardiologists and cardiac surgeons around the 
world in quest of definitive repair of as many complex 
anomalies as existed in need of repair. 
The postoperative complication of postpericardiotomy 
syndrome was created when intrapericardial surgery for 
heart disease came into being (15,16). This entity required 
recognition for what it was and for what it was not (not 
sepsis, endocarditis or reactivation of rheumatic fever) and 
for the fact that it was self-limited and usually did not recur. 
Critical analysis of operative mortality, morbidity and short- 
as well as long-term results refined the selection of cases and 
improved the results of cardiac surgery. 
Interventional pediatric cardiology. The 1960s witnessed 
the perfection of catheterization techniques for infants rec- 
ognized to be critically in need of medical or surgical help, or 
both. Rashkind (17) became the father of interventional 
cardiology when he introduced the balloon catheter creation 
of an atria1 septal defect as life-saving palliation for the 
cyanotic newborn with complete transposition of the great 
arteries. This accomplishment for such neonates was 
matched by the effective surgical physiologic repair in chil- 
dren by the venous switch operation of William Mustard 
(18). This procedure rerouted venous return to the atria to 
match the transposed great arteries, thereby achieving phys- 
iologic blood flow and conversion of a sickly, cyanotic 
patient to a pink, healthy one. 
The 1970s saw two major diagnostic and surgical ad- 
vances in this leapfrogging of medical and surgical improve- 
ments in the care of congenital heart disease. Let us 
consider the surgical accomplishments first. Since the 1950s 
the importance of severe congenital heart disease in young 
infants had been appreciated, but the risks in efforts at 
surgical salvage were still high. The sad story was that only 
half of these critically affected babies reached their first 
birthday, and that most deaths due to congenital heart 
disease occurred in the first 3 to 6 months of life. A 
combination of events in the 1970s changed that: miniatur- 
ization of equipment in laboratories and operating rooms, 
monitoring and ventilatory support in neonatal and pediatric 
intensive care units and skills in sophisticated anesthesio- 
logic management. Added to these were the surgical tech- 
niques of hypothermia combined with cardiopulmonary by- 
pass and the development by Barratt-Boyes and colleagues 
(19) in New Zealand of the use of profound hypothermia and 
circulatory arrest. 
All of these measures accomplished more saving of lives 
for babies with cyanotic and acyanotic anomalies. Previ- 
ously, such children often died before reaching the suitable 
and safe age of 5 or 6 years for surgery with cardiopulmonary 
bypass. The door was now open for early repair as the 
definitive procedure in infancy rather than later repair in 
childhood after palliation in infancy. Babies born with the 
common anomalies of large ventricular septal defect or with 
tetralogy of Fallot benefited especially by this new approach 
to open repair. In this country, Paul Ebert (20) and Aldo 
Castaneda (21) and their coworkers led in the excellent 
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results of surgery for infants with severe congenital heart 
disease. 
Advances in the diagnosis of congenital heart disease. The 
major advance in diagnosis in the 1970s was the advent of 
echocardiography. at first M-mode and then two-dimen- 
sional (22). At the outset, this imaging technique was vali- 
dated by comparison with the findings at cardiac catheter- 
ization with contrast visualization. As credibility was 
established, echocardiography came to be used increasingly 
to confirm the clinical diagnosis in mild or moderately severe 
conditions where cardiac catheterization would not ordi- 
narily be needed, and to be used in serial, noninvasive 
follow-up of patients with unoperated or postoperative con- 
genital heart disease. Next it began to replace cardiac 
catheterization as confirmation of diagnosis for patients 
undergoing cardiac surgery on their malformation (23). This 
trend increased as Doppler methodology was added in the 
1980s. 
Recent medical and surgical progress. Other improve- 
ments in treatment in the 1970s were both medical and 
surgical. Management of cardiac failure was helped greatly 
by the introduction of an effective diuretic, furosemide (24), 
and by the use, when necessary, of afterload-reducing drugs. 
New antiarrhythmic agents helped to control difficult prob- 
lems and new antibiotics were developed that helped cure 
infections due to resistant organisms. 
Phurmacologic manipulmtions of the ductus cwteriosus 
often accomplished its closure when it was open and phys- 
iologically significant in very small premature babies. The 
agent employed, indomethacin, was a prostaglandin- 
synthetase inhibitor (25,26). The converse effect involved 
the use of prostaglandin in newborns to maintain temporary 
patency of the ductus arteriosus until diagnosis and surgery 
could be performed. For instance, a baby whose survival 
depends on patency of the ductus because of severe congen- 
ital pulmonary atresia or stenosis needs an open ductus to 
shunt blood left to right into the pulmonary circuit (27). 
Alternatively, the infant with severe coarctation of the aorta 
also needs a patent ductus to permit a right to left shunt from 
the pulmonary artery to the descending aorta to maintain 
flow into the descending aorta. The neonate with complete 
transposition of the great arteries may benefit from a patent 
ductus to provide bidirectional shunting as a temporary 
measure. The temporary induction of patency of the ductus 
in these critically ill newborns permitted stabilization of their 
condition and the avoidance of middle of the night, high risk 
cardiac catheterization and emergency surgery. 
Surgical inventiveness in the use of externrrl conduits to 
connect rhe right \>entricle to the pulmonary artery in con- 
ditions of truncus arteriosus and pulmonary atresia was led 
by Dwight McGoon and his coworkers (28). Francis Fontan 
(29) introduced the revolutionary concept that, in the mal- 
formation of tricuspid atresia and rudimentary right ventricle 
with diminished pulmonary blood flow, the right atrium 
alone could serve to receive systemic venous return and 
deliver it to the pulmonary circulation. Fontan, of Bordeaux, 
France and William Kreutzer (30), of Buenos Aires, Argen- 
tina independently demonstrated that this approach afforded 
a new kind of palliation that separated systemic and pulmo- 
nary circulations. Jatene and coworkers (31) introduced the 
arterial switch operation for transposition of the great arter- 
ies. Critical analysis of results modified criteria for selection 
for surgery and perioperative management so that mortality 
rates began to decline. Surgical suppression of accessory 
conduction pathways began to be used to treat people with 
Wolff-Parkinson-White syndrome and serious arrhythmias 
refractory to usual drug therapy (32). 
The team approach. During the 1960s and 197Os, orga- 
nized medicine and the health care system articulated and 
formalized guidelines for centers of excellence in the short- 
and long-term care of people with congenital heart disease. 
The Intersociety Commission on Heart Disease Resources, 
headed by cardiologist Irving Wright, published a series of 
guidelines for optimal care (33,34). The American College of 
Cardiology was a participating society. These guidelines 
emphasized the team approach with trained medical and 
pediatric cardiologists. cardiac surgeons, anesthesiologists, 
pathologists, nurses and related professional personnel and 
social services. all working in coordination and cooperative 
collaboration in a center well equipped and staffed for 
diagnosis and medical-surgical care and follow-up. 
The 1980s have seen the flowering of the field of echocar- 
diogrrrphp biith Doppler and Doppler color flow mapping 
studies that not only image defects but also quantitate 
physiologic events of flow and pressure. In many instances 
Doppler studies have become the standard, replacing cardiac 
catheterization as the first confirmation of diagnosis and in 
follow-up. Radionuclide cineangiocardiography (35) and nu- 
clear magnetic resonance imaging (36) and digital subtraction 
angiocardiography (37) have enhanced imaging capabilities 
with minimal or no invasive aspect to the study. 
Yet the cardiac catheterization laboratories continue to 
be busy as they carry out electrophysiologic studies (38) of 
extraordinary arrhythmias and perform invasive cardiovas- 
cular therapy. Jean Kan and coworkers (39) of Johns Hop- 
kins demonstrated the safety and efficacy of balloon dilation 
of the moderately or severely stenotic pulmonary valve. This 
is now widely accepted as an alternative to open heart 
surgery for relief of the obstruction. James Lock and other 
interventional cardiologists are carefully performing and 
analyzing other balloon dilations that are not yet so success- 
ful and remain investigational, such as dilation of native 
coarctation (40). congenital valvular aortic stenosis (41) or 
peripheral pulmonary stenosis (42). 
Crrrdio~~rrsc,lrlar surgical tellms proceed btith meticulous 
ewe to repciir. often in very young infrtits. even the most 
complex ofnnomcrlies. William Norwood and colleagues (43) 
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accepted the ultimate surgical challenge for salvage of a 
desperate situation when they carried out the first of several 
proposed stages of palliation for the usually lethal and all too 
common hypoplastic left heart syndrome. Mechanical valves 
are long lasting, and sometimes the native valve may be 
rendered functional after surgery. Aortic homografts are 
more readily available for external conduits than in the past. 
Pacemakers are sophisticated, miniaturized and longer last- 
ing (44). Heart transplantation is saving lives, even in 
childhood (43, and heart-lung transplantation offers hope of 
redemption to some patients with Eisenmenger syndrome. 
This recital of developments that took us to where we are 
today is liberally laced with surgical names, which pays due 
respect to but unfair emphasis on one important group of the 
team that brought the care of people with congenital heart 
disease to this high state of the art. Procedures tend to have 
names attached, whereas medical diagnosis and care do not. 
As these surgeons would quickly agree, the success of a 
surgical technique depends not only on the concept, the 
research and development and the skill in the operating 
room. It also requires the correct diagnosis of the patient by 
the cardiologist, the careful selection for surgery by both 
partners of the team and preoperative and postoperative 
team care. Thereafter, their partner in pediatric cardiology 
carries out long-term postoperative follow-up with analysis 
of outcome so that results can be continuingly improved. 
Many giants in the field of pediatric cardiology contributed 
their skills, talents, research, teaching and warm-hearted 
care of the patients to this chronicle of the growth and 
development of high quality care in congenital heart disease. 
Most people with cardiac birth defects do not require cardiac 
surgery; they have also been helped by what we have 
learned from the surgical experience. 
The future. What does the future hold? I wouldn’t dare to 
guess! State-of-the-art care as it has developed decade by 
decade over the past 50 years has without question saved 
lives and made longer lives healthier. It has accomplished 
the mission of the American College of Cardiology and 
American Heart Association by preventing disability and 
premature death for thousands of people born with cardio- 
vascular malformations. 
Future developments will continue to build on past 
knowledge and will employ the team approach with each 
member contributing clinical and research abilities and med- 
ical, pediatric, surgical, nursing, technical, social, engineer- 
ing and laboratory skills in centers with up to date facilities 
for ambulatory and in-patient diagnosis and treatment, both 
medical and surgical. Early diagnosis and compassionate, 
long-term, informed care will always be important. During 
the present and on into the future, just as in the past, we do 
well to remember that in state of the art care, sympathetic 
understanding and knowledgeable care are the key. 
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